Asenze Study 2008-2012, Waves 1 and 2
South Africa, 2008 - 2012
Get Microdata
Reference ID
zaf-ukzn-cu-az-2008-2012-v1
Producer(s)
University of KwaZulu-Natal, Columbia University
Collections
Metadata
Created on
May 02, 2025
Last modified
Jun 03, 2025
Page views
4203
Downloads
24
- Data files
- asenze-2008-2012-w1-2-v1
{maf600} Medication 3: (MAF600W2)
Data file: asenze-2008-2012-w1-2-v1
Overview
Valid:
65
Invalid:
0
Type:
Discrete
loc_start_pos:
7972
loc_end_pos:
8005
Width:
34
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 99 | 11 |
16.9%
|
|
| ADCO-CIMETIDINE 400 MG | 1 |
1.5%
|
|
| ARTHIRITIS MEDICATION | 3 |
4.6%
|
|
| ARTHIRITIS PILLS | 1 |
1.5%
|
|
| ARTHRITIS MEDICATION | 2 |
3.1%
|
|
| ATENOLOL50MG | 1 |
1.5%
|
|
| B.CO | 2 |
3.1%
|
|
| B.TABLETS | 1 |
1.5%
|
|
| BACTRIM | 3 |
4.6%
|
|
| BATRIM | 1 |
1.5%
|
|
| BCO | 1 |
1.5%
|
|
| BCOMPLEX | 1 |
1.5%
|
|
| BP MED, ADTHMA MED | 1 |
1.5%
|
|
| BP MEDICATION | 3 |
4.6%
|
|
| BP TABLETS | 1 |
1.5%
|
|
| BP TREATMENT | 1 |
1.5%
|
|
| DIABETES MEDICATION | 1 |
1.5%
|
|
| DIABETES MEDICINE | 1 |
1.5%
|
|
| DIABETES TABLETS | 1 |
1.5%
|
|
| DIABETES TREATMENT | 1 |
1.5%
|
|
| DIABETS | 1 |
1.5%
|
|
| DICHLOPHENAC | 1 |
1.5%
|
|
| ELNAPRIL | 1 |
1.5%
|
|
| EPILEPSY MODICATION | 1 |
1.5%
|
|
| FOLIC ACID | 2 |
3.1%
|
|
| HEART TREATMENT | 1 |
1.5%
|
|
| HUMILIN 30/70 | 1 |
1.5%
|
|
| HYPERTENSION MEDICATION | 3 |
4.6%
|
|
| METPHORMIN | 1 |
1.5%
|
|
| MULTIVITAMIN | 1 |
1.5%
|
|
| NEZIUM | 1 |
1.5%
|
|
| PHARMA PRESS 10 MG & RIDAQ 12.5 MG | 1 |
1.5%
|
|
| PHARMAPRESSS 10 MG | 2 |
3.1%
|
|
| PHERNOBARD | 1 |
1.5%
|
|
| PREGMAL | 1 |
1.5%
|
|
| PYRIDOXINE 25 MG | 1 |
1.5%
|
|
| RIDAQ | 1 |
1.5%
|
|
| RIDAQ 12.5 MG | 2 |
3.1%
|
|
| RIDAQ 2.5 MG | 1 |
1.5%
|
|
| RIDAQ 250 MG | 1 |
1.5%
|
|
| TEGRETAL 400MG | 1 |
1.5%
|
|
| VITAMIN TABLETS | 1 |
1.5%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.